Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Files, Clark
GRAIL^3, NCT04706507: Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis	Active, not recruiting	3	500	US	IV Ganciclovir, Cytovene	Fred Hutchinson Cancer Center, National Heart, Lung, and Blood Institute (NHLBI)	Acute Respiratory Failure	10/24	08/27
NECTAR, NCT04924660: Novel Experimental COVID-19 Therapies Affecting Host Response	Completed	2/3	871	US	TXA127, TRV027, Placebo, Fostamatinib	Sean Collins, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)	COVID-19, SARS-CoV-2 Infection, Coronavirus Infection	10/23	12/23
WFIT, NCT04576065: Wake Forest Post-ICU Telehealth () Program	Completed	N/A	413	US	WFIT	Wake Forest University Health Sciences	Critical Illness	09/23	09/23